A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified June 2012 by McMaster University
Sponsor:
Collaborators:
GlaxoSmithKline
Hamilton Health Sciences Corporation
Information provided by (Responsible Party):
Donald Arnold, McMaster University
ClinicalTrials.gov Identifier:
NCT01621204
First received: June 12, 2012
Last updated: June 15, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)